Petru I. Ifteni
56 Nicolae Bălcescu Str
Brasov, BV 500019, Romania
Brasov, BV 500019, Romania
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 48 publications
Second-Generation Long-Acting Injectable Antipsychotics: A Comprehensive Assessment of Effectiveness, Safety, and Cost.
Journal: Neuropsychiatric disease and treatment
Published: March 16, 2026
Patterns of onset and progression of psychoses induced by psychoactive substance use.
Journal: Psychiatry research
Published: February 04, 2026
Mental health, coping and related risk factors during the first 2 years of the COVID-19 pandemic in children: Nationally representative, multi-wave, cross-sectional results from 12 countries from the global COH-FIT study.
Journal: European neuropsychopharmacology : the journal of the European College of Neuropsychopharmacology
Published: October 09, 2025
Trends in Sudden Death Among Schizophrenia Inpatients.
Journal: Medicina (Kaunas, Lithuania)
Published: October 09, 2025
Xanomeline/Trospium (Cobenfy): A Novel Approach for the Treatment of Schizophrenia in Adults.
Journal: American journal of therapeutics
Published: October 07, 2025
Correction: Rating opportunity for long-acting injectable antipsychotic initiation index (ROLIN).
Journal: Frontiers in psychiatry
Published: October 03, 2025
Correction: The antipsychotics functional index (AFI) in schizophrenia.
Journal: Frontiers in pharmacology
Published: July 08, 2025
Pre- and Post- COVID-19 Pandemic Pneumonia Rates in Hospitalized Schizophrenia Patients.
Journal: Medicina (Kaunas, Lithuania)
Published: June 06, 2025
A review of functionality assessment scales in schizophrenia.
Journal: Frontiers in psychiatry
Published: June 04, 2025
What is behind the 17-year life expectancy gap between individuals with schizophrenia and the general population?
Journal: Schizophrenia (Heidelberg, Germany)
Published: May 27, 2025
The antipsychotics functional index (AFI) in schizophrenia.
Journal: Frontiers in pharmacology
Published: March 11, 2025
EGb761 Trials for Mild-to-Moderate Dementia-What Have We Learned in the Past 18 years?
Journal: American journal of therapeutics
Published: January 10, 2025
Last Updated: 09/26/2026